¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"ȯ"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • case referent study
    ȯÀÚ´ëÁ¶±º¿¬±¸
  • case-control study
    ȯÀÚ´ëÁ¶±º¿¬±¸, »ç·Ê´ëÁ¶±º¿¬±¸
  • case finding program
    ȯÀڹ߰߰èȹ, ȯÀڹ߰߻ç¾÷
  • spot map
    ȯÀڹ߻ýÁöµµ
  • spot mapping
    ȯÀڹ߻ýÁöµµÀÛ¼º
  • flying ambulance
    ȯÀÚ¼ö¼ÛºñÇà±â, ±¸±ÞºñÇà±â
  • air ambulance
    ȯÀÚ¼ö¼ÛÇ×°ø±â, ±¸±ÞÇ×°ø±â
  • stretcher
    ȯÀÚ¿î¹ÝÂ÷, µé°Í
  • patient positioning
    ȯÀÚÀ§Ä¡°áÁ¤
  • patient triggered respirator
    ȯÀÚÀ¯¹ß½ÄÈ£Èí±â
  • patient triggered ventilator
    ȯÀÚÀ¯¹ß½Äȯ±â±â
  • patient identification
    ȯÀÚÈ®ÀÎ
  • auditory hallucination
    ȯû, ¼Ò¸®È¯°¢
  • auditory hallucinosis
    ȯûÁõ, ¼Ò¸®È¯°¢Áõ
  • annelid
    ȯÇüµ¿¹°
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • circulator
    ¼øÈ¯±â
  • circulatory
    ¼øÈ¯-
  • circulatory arrest
    ¼øÈ¯Á¤Áö
  • circulatory collapse
    ¼øÈ¯ÇãÅ»
  • circulatory congestion
    ¼øÈ¯¿ïÇ÷
  • circulatory failure
    ¼øÈ¯±â´É»ó½Ç, ¼øÈ¯ºÎÀü
  • circulatory shock
    ¼øÈ¯¼îÅ©
  • circulatory system
    ¼øÈ¯°èÅë, ¼øÈ¯°è
  • circumferential lamella
    µÑ·¹ÃþÆÇ, ȯ»óÃþÆÇ
  • class switch
    Ŭ·¡½ºÀüȯ, Ŭ·¡½º½ºÀ§Ä¡
  • closed circuit anesthesia
    Æó¼â¼øÈ¯¸¶Ãë
  • collar crown
    ´ëȯÀÇÄ¡°ü, Ä®¶ó°ü
  • collateral circulation
    °ç¼øÈ¯
  • command hallucination
    ¸í·Éȯ°¢
  • commitment index
    ³»¿øÈ¯ÀÚÁö¿ªº°±¸¼ºµµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • critically ill patient
    ÁßȯÀÚ
  • phantom phenomenon
    ÇêÇö»ó, ȯ»óÇö»ó
  • phantom pain
    ÇêÅëÁõ, ȯ»óÅëÁõ
  • phantom limb pain
    Çê´Ù¸®ÅëÁõ, ÇêÆÈÅëÁõ, ȯ»óÁöÅëÁõ
  • refusion
    ¼øÈ¯Àç°³
  • replacement
    ´ëÄ¡(¼ú), ±³È¯, ġȯ
  • revolver
    ȸÀü±³È¯±â, ȸÀü±â
  • recirculation
    Àç¼øÈ¯
  • redressement
    ¹Ýº¹°ÅÁȯ(¼ú)
  • reduction
    1.¸ÂÃã, ±³Á¤, Á¤º¹, 2.ȯ¿ø, Ãà¼Ò
  • alveolar ventilation rate
    ÇãÆÄ²Ê¸®È¯±âÀ², ÆóÆ÷ȯ±âºñ
  • case morbidity rate
    Áõ·ÊÀÌȯÀ²
  • doctor-patient relationship
    ÀÇ»çȯÀÚ°ü°è
  • morbidity rate
    ÀÌȯ·ü
  • sexual reversion
    ¼ºÀüȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • phantom phenomenon
    ȯ»óÇö»ó, ÆÇÅèÇö»ó
  • pseudopsia
    ȯ½Ã
  • visual hallucination
    ȯ½Ã, º¸ÀÓȯ°¢
  • globulus
    ȯ¾à, °ø, ±¸Ã¼, µ¢¾î¸®
  • reducing sugar
    ȯ¿ø´ç
  • reducing atmosphere
    ȯ¿ø´ë±â
  • reducing substance
    ȯ¿ø¹°Áú
  • reducibility
    ȯ¿ø¼º
  • reducible
    ȯ¿ø¼º-
  • reduction test
    ȯ¿ø½ÃÇè
  • reducing factor
    ȯ¿øÀÎÀÚ
  • reductimetry
    ȯ¿øÀûÁ¤
  • reduction potential
    ȯ¿øÀüÀ§
  • reductant
    ȯ¿øÁ¦
  • reducing agent
    ȯ¿øÁ¦, ȯ¿ø½Ã¾à
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • convertase
    Àüȯȿ¼Ò
  • converter
    Àüȯ±â, º¯È¯±â
  • cretin
    Å©·¹Æ¾º´È¯ÀÚ
  • crossingover
    ±³Â÷, ±³¹è, À¯ÀüÀÚ±³È¯
  • cryptorchid
    Àẹ°íȯ-
  • cryptorchidectomy
    Àẹ°íȯÀýÁ¦(¼ú)
  • cryptorchidism
    Àẹ°íȯÁõ
  • cryptorchidopexy
    (¢¡orchiopexy) °íȯ°íÁ¤¼ú
  • cryptorchism
    (¢¡cryptorchidism) Àẹ°íȯÁõ
  • cycle
    ÁÖ±â, ¼øÈ¯, ȸ·Î, Á֯ļö
  • cyclic
    ÁÖ±â-, ¼øÈ¯-, ȸ·Î-, °í¸®-
  • cycling
    ¼øÈ¯¼º
  • cycloid
    ¼øÈ¯Çü-
  • cyclomere
    µ¹¸²ºÐÀý, ȯ»óüÀý
  • cyclosis
    ¼¼Æ÷Áúȯ·ù
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • reduction test
    ȯ¿ø½ÃÇè.
  • reducing factor
    ȯ¿øÀÎÀÚ.
  • reductimetry
    ȯ¿øÀûÁ¤(ü½êªîÙïá).
  • reduction potential
    ȯ¿øÀüÀ§.
  • reducing agent
    ȯ¿øÁ¦(ü½êªð¥), ȯ¿ø½Ã¾à.
  • reductant
    ȯ¿øÁ¦(ü½êªð¥).
  • reduced iron ³ª ferrum reductum
    ȯ¿øÃ¶(ü½êªôÑ).
  • reducible
    ȯ¿øÇÒ ¼ö ÀÖ´Â.
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò(ü½êª úìßäáÈ).
  • reduced hemoglobin
    ȯ¿øÇ÷»ö¼Ò(ü½êªúìßäáÈ)
  • reduction semiconductor
    ȯ¿øÇü¹ÝµµÃ¼(ü½êªû¡ÚâÓôô÷).
  • reduced flavoprotein
    ȯ¿øÇüÇö󺸴ܹéÁú.
  • reductase
    ȯ¿øÈ¿¼Ò
  • redoxin
    ȯ¿øÈ¿¼Ò(ü½êªý£áÈ), ·¹µ¶½Å.
  • reducase
    ȯ¿øÈ¿¼Ò(ü½êªý£áÈ).
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • acute illness policy
    ±Þ¼ºÁúȯÁ¤Ã¥<--¹æÄ§>
  • acute infectious disease
    ±Þ¼º °¨¿°Áúȯ
  • acute orchitis
    ±Þ¼º °íȯ¿°
  • acute rheumatism
    ±Þ¼º ·ù¸¶Æ¼½ºÁúȯ.
  • acute transforming virus
    ±Þ¼º ÇüÁúÀüȯ ¹ÙÀÌ·¯½º
  • acute transforming virus
    ±Þ¼ºÇüÁúÀüȯ¹ÙÀÌ·¯½º
  • acyclia
    ¼øÈ¯Á¤Áö(âàü»ïÎò­).
  • acyclic compound
    ºñȯ»óÈ­ÇÕ¹°.
  • adenofibroma, of testis
    °íȯ ¼±¼¶À¯Á¾
  • adipose tissue disease
    Áö¹æÁ¶Á÷Áúȯ.
  • admitted patient
    ÀÔ¿øÈ¯ÀÚ.
  • adrenal disorders
    ºÎ½ÅÀå¾Ö, ºÎ½ÅÁúȯ.
  • air borne disease
    °ø±â¸Å°³Áúȯ.
  • air space disease
    °ø±â °ø°£ Áúȯ
  • air-fluid exchange
    °ø±â¾×ü±³È¯
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • mesology
    ȯ°æÇÐ(̷˭̰).
  • environmental antigen
    ȯ°æÇ׿ø
  • eunuchism
    ȯ°üÁõ(ü²Î¯ñø).
  • ventilation
    ȯ±â
  • ventilatory failure
    ȯ±â ºÎÀü
  • ventilator mode
    ȯ±â ¾ç½Ä
  • ventilation
    ȯ±â, Åë±â
  • ventilation blood flow ratio
    ȯ±â-Ç÷·ùºñÀ²(üµÑ¨úìêüÝïëÒ).
  • ventilation/perfusion ratio
    ȯ±â/°ü·ùºñ
  • ventilation coefficient
    ȯ±â°è¼ö(̷˻˭Ëà).
  • overventilation
    ȯ±â°úÀ×(üµÑ¨Î¦í¥), °úȯ±â.
  • tube, ventilating
    ȯ±â°ü
  • ventilating tube
    ȯ±â°ü
  • ventilation perfusion ratio
    ȯ±â°ü·ùºñ
  • ventilation perfusion ratio
    ȯ±â°ü·ùºñ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • analog to digital converter
    ¾Æ³ª·Î±× µðÁöÅ» º¯È¯±â
  • anchor band
    À¯Áö´ëȯ(ë«ò¥Óáü»).
  • anchor clamp band
    À¯Áö´ëȯ.
  • andersen disease
    ¾Ø´õ½¼º´<--Áúȯ>
  • anemia,myelophthisic
    °ñ¼öġȯ¼º(ÍéâÐöÇüµàõ) (ºóÇ÷)(Þ¸úì)
  • angiocardiology
    1. ½ÉÇ÷°üº´ÇÐ(ãýúìηܻ ùÊ). 2. ¼øÈ¯±âÇÐ(âàü»ÐïùÊ).
  • angiosis
    Ç÷°üÁúȯ(úìηòðü´).
  • angiospasmodic disease
    Ç÷°ü¿¬Ã༺ Áúȯ.
  • angiotensin converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò.
  • angiotensin converting enzyme inbibitor
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
  • angiotensin converting enzyme inhibitor
    ¾ÈÁö¿ÀÅٽŠÀüȯȿ¼Ò ¾ïÁ¦¹°Áú<¾à>.
  • angiotensin-converting enzyme
    ¾ÈÁö¿ÀÅÙ½ÅÀüȯȿ¼Ò
  • anion exchange chromatography
    À½À̿±³È¯Å©·Î¸¶Åä±×·¡ÇÇ
  • anion exchange protein
    À½À̿ ±³È¯ ´Ü¹é(ÎßüµÓ±ÛÜ)
  • anion exchange resin
    À½À̿±³È¯¼öÁö
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • Mesorchium
    °íȯ°£¸·
    [¿¾ ¿ë¾î] °íȯ°£¸·
  • Rete testis
    °íȯ±×¹°
    [¿¾ ¿ë¾î] °íȯ(Á¤¼Ò)¸Á
  • Rete testis
    °íȯ±×¹°
    [¿¾ ¿ë¾î] °íȯ[Á¤¼Ò]¸Á
  • Rete testis
    °íȯ±×¹°
    [¿¾ ¿ë¾î] °íȯ¸Á
  • Ductulus efferens testis
    °íȯ³¯¼¼°ü
    [¿¾ ¿ë¾î] °íȯ(Á¤¼Ò)¼öÃâ°ü
  • Efferent ductules of testis
    °íȯ³¯¼¼°ü
    [¿¾ ¿ë¾î] °íȯ¼öÃâ°ü
  • Descent of testis
    °íȯ³»¸²
    [¿¾ ¿ë¾î] °íȯÇϰ­
  • Septum testis
    °íȯ»çÀ̸·
    [¿¾ ¿ë¾î] °íȯ(Á¤¼Ò)Áß°Ý
  • Septum testis
    °íȯ»çÀ̸·
    [¿¾ ¿ë¾î] °íȯÁß°Ý
  • Septums of testis
    °íȯ»çÀ̸·
    [¿¾ ¿ë¾î] °íȯÁß°Ý
  • Interstitium of testis
    °íȯ»çÀÌÁú
    [¿¾ ¿ë¾î] °íȯ°£Áú
  • Interstitium testis
    °íȯ»çÀÌÁú
    [¿¾ ¿ë¾î] °íȯ[Á¤¼Ò]°£Áú
  • Lobule of testis
    °íȯ¼Ò¿±
    [¿¾ ¿ë¾î] °íȯ(Á¤¼Ò)¼Ò¿±
  • Lobule of testis
    °íȯ¼Ò¿±
    [¿¾ ¿ë¾î] °íȯ[Á¤¼Ò]¼Ò¿±
  • Lobules of testis
    °íȯ¼Ò¿±
    [¿¾ ¿ë¾î] °íȯ¼Ò¿±
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
  • unformed h.
    ºñÁ¤Çüȯ°¢
    ÞªïÚû¡ü³ÊÆ
  • visual h.
    º¸ÀÓȯ°¢, ȯ½Ã
    ü³ãÊ
  • ¤Ñ cerebrovascular disease
    ÃâÇ÷³úÇ÷°üÁúȯ
    õóúìÒàúìηòðü´
  • high positive pressure ventilation
    °í¾ç¾Ðȯ±â
    ÍÔåÕäâüµÑ¨
  • ¤Ñ vascular disease
    °íÇ÷¾ÐÇ÷°üÁúȯ
    ÍÔúìäâàõúìηòðü´
  • ¤Ñ arterial occlusive disease
    µÎ°³°­³»µ¿¸ÆÆó¼â¼º Áúȯ
    ÔéËÏË·Ò® ÔÑØæøÍáðàõ òðü´
  • ¤Ñ circulation
    µÎ°³°­³»¼øÈ¯
    ÔéËÏË·Ò® âàü»
  • inversion
    ÀÚ¸®¹Ù²Þ, ¾ÈÂʹøÁü, ³»¹ÝÁõ, ÀüÀ§, Àüȯ
    Ò®Úãñû, ï®êÈ, ï®üµ
  • ¤Ñ bone disease
    ´ë»ç¼º°ñÁúȯ
    ÓÛÞóàõÍéòðü´
  • microcirculation
    ¹Ì¼¼¼øÈ¯
    Ú°á¬âàü»
  • minute ventilation
    ºÐ´çȯ±â·®
    ÝÂÓ×üµÑ¨Õá
  • morbidity (rate)
    ÀÌȯ(À²)
    ìºü´(ëÒ)
  • negative
    À½¼ºµÇ¸ÔÀ̱â, À½¼º±Íȯ
    ëäàõÏýü½
  • ¤Ñ feedback
    À½¼º µÇ¸ÔÀ̱â, À½¼º±Íȯ
    ëäàõÏýü½
  • neurodegenerative disease
    ½Å°æº¯¼ºÁúȯ
    ãêÌèܨàõòðü´
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • freeze-substitution
    ¾ó¸²Ä¡È¯(öÇüµ)
  • Gaucher's disease
    °í¿À¼Å Áúȯ(òðü´)
  • gene conversion
    À¯ÀüÀÚ Àüȯ(ë¶îîí­ï®üµ)
  • gene substitution
    À¯ÀüÀÚ Ä¡È¯(ë¶îîí­öÇüµ)
  • genetic disease
    À¯Àü Áúȯ(ë¶îîòðü´)
  • Gilbert's disease
    ±æ¹öÆ® Áúȯ(òðü´)
  • glycogen storage disease
    ±Û¶óÀÌÄÚÀü ÀúÀå Áúȯ(îÍíúòðü´)
  • Hartnup's disease
    ÇÏÆ®³Ò Áúȯ(òðü´)
  • heavy-chain disease
    Áß(ñì)»ç½½ Áúȯ(òðü´)
  • Hers' disease
    ¿¡¸£½º Áúȯ(òðü´)
  • Hershey circle
    Çã½Ãȯ(ü»)
  • hydrogen exchange
    ¼ö¼Ò ±³È¯(â©áÈÎßüµ)
  • hydrogen iostope exchange
    ¼ö¼Ò µ¿À§¿ø¼Ò ±³È¯(â©áÈÔÒêÈêªáÈÎßüµ)
  • I-cell disease
    I-¼¼Æ÷ Áúȯ(á¬øàòðü´)
  • immune deficincy disease
    ¸é¿ª °áÇÌ Áúȯ(Øóæ¹ÌÀù¹òðü´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • fantasy
    °ø»ó, ȯ»ó
  • fast Fourier transform
    °í¼ÓFourierº¯È¯
  • feedback
    µÇ¸ÔÀ̱â, ±Íȯ
  • fetal circulation
    žƼøÈ¯, žÆÇ÷Çà
  • focal disease
    ÃÊÁ¡¼ºÁúȯ
  • Fourier transform [=FT]
    Fourierº¯È¯
  • glycogen storage disease
    ±Û¸®ÄÚ°Õ ÃàÀûÁúȯ
  • granule
    °ú¸³, ȯ¾à
  • granulomatous disease
    À°¾ÆÁ¾¼ºÁúȯ
  • hematopoietic disease
    Á¶Ç÷¼ºÁúȯ
  • Henle's loop
    Çﷹȯ, Çî·¹°èÁ¦, Çî·¹°í¸®, ¼¼´¢°ü°èÁ¦
  • hyperperfusion
    °ú¼øÈ¯
  • hypertensive vascular disease
    °íÇ÷¾Ð¼ºÇ÷°üÁúȯ
  • hyperventilation
    °úȯ±â, ȯ±âÇ×Áø, È£ÈíÇ×Áø, °úÈ£Èí
  • hypothalamic disorder
    ½Ã»óÇϺÎÁúȯ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • B25.8
    Other cytomegaloviral diseases
    ±âŸ °Å´ë¼¼Æ÷¹ÙÀÌ·¯½º Áúȯ
  • B26.0+
    Mumps orchitis)(N51.1 *
    º¼°Å¸® °íȯ¿°
  • B33
    Other viral diseases, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ±âŸ ¹ÙÀÌ·¯½º Áúȯ
  • B33.8
    Other specified viral diseases
    ±âŸ ¸í½ÃµÈ ¹ÙÀÌ·¯½º Áúȯ
  • B60
    Other protozoal diseases, NEC
    ´Þ¸® ºÐ·ùµÇÁö ¾ÊÀº ±âŸ ¿øÃæÁúȯ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • patient exposure
    ȯÀÚ ³ëÃâ
  • case control study
    ȯÀÚ ´ëÁ¶ ¿¬±¸
  • case finding program
    ȯÀÚ ¹ß°ß °èȹ, ȯÀÚ ¹ß°ß »ç¾÷
  • patient protection
    ȯÀÚ ¹æ¾î
  • air ambulance
    ȯÀÚ ¼ö¼Û ºñÇà±â
  • patient charting
    ȯÀÚ Ã­Æ® ÀÛ¼º
    ȯÀÚÀÇ Áø´Ü ¹× Ä¡·á¿¡ ÇÊ¿äÇÑ ÀûÀýÇÑ Á¤º¸¸¦ ±â·Ï, ÀÛ¼ºÇÏ´Â °Í.
  • patient identification
    ȯÀÚ È®ÀÎ
  • between-patient variability
    ȯÀÚ°£ º¯È­
  • patient's expectation
    ȯÀÚÀÇ ±â´ë
  • patient coping style
    ȯÀÚÀÇ ´ëó ¾ç½Ä
  • patient's perception
    ȯÀÚÀÇ ÀÎÁö
  • patient's compliance
    ȯÀÚÀÇ ÀûÀÀ
  • pilula
    ȯÁ¦, ȯ¾à
  • acouasm
    ȯû
  • acousma
    ȯû
    »ó»óÀÇ À½.
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • case control study
    ȯÀÚ ´ëÁ¶ ¿¬±¸
  • case finding program
    ȯÀÚ ¹ß°ß °èȹ, ȯÀÚ ¹ß°ß »ç¾÷
  • casual
    ¿ì¹ß¼ºÀÇ, ±¸±Þ ȯÀÚ
    ¿ì¹ß¼ºÀÇ, º´¿ø ±¸±Þ ħ´ë¿¡ Àִ ȯÀÚ.
  • cation exchanger
    ¾ç À̿ ±³È¯Ã¼
  • CDA certified dentual assistantÀÇ ¾àÀÚ.

    CDC

    Áúȯ Á¶Àý ¹× ¿¹¹æ ¼¾ÅÍ
    Centers for Disease Control and PreventionÀÇ ¾àÀÚ.
  • cell substitution
    ¼¼Æ÷ ġȯ, Ç÷±¸ Àç»ý
  • chart
    ȯÀÚ ±â·ÏÁö, µµÇ¥, ÇØµµ, º´·ÂÁö
    ¾î¶² º¯¼ö, ¿¹ÄÁ´ë ¸Æ¹Ú, ü¿Â, È£Èí¼ö º¯µ¿ µîÀÇ ´Ü¼øÈ­µÈ ±×¸² Ç¥½Ã, ¶Ç´Â ƯÁ¤ÇÑ Áõ·Ê ÀüüÀÇ ÀÓ»ó ¼Ò°ßÀÇ ±â·Ï.
  • chemical environment
    È­ÇРȯ°æ
  • chop amputation
    Æò¸é ȯ»ó Àý´Ü
  • chromesthesia
    »ö ȯ°¢
    ½ÇÁ¦ÀÇ Ã»°¢, ¹Ì°¢, Èİ¢¿¡ ¼ö¹ÝÇÏ¿© ÀϾ´Â »öäÀÇ È¯°¢.
  • chromophose
    »ö°¨ ȯ°¢, ÁÖ°üÀû »ö°¢
  • cicumcision
    ȯ»ó ÀýÁ¦¹ý
  • circular
    ȯ»ó, À±»ó
  • circular chromosome
    ȯ»ó ¿°»öü
  • circular insanity
    ¼øÈ¯ Á¤½Å ÀÌ»ó
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
Ä«µð¾ÆÁªÁ¤90mg - »õâ
ȯÀÎÁ¦¾à
A09701951 Diltiazem HCl
Àü¹®ÀǾàǰ | ±Þ¿©
ȯÀÎÈ÷´ÜÅäÀÎÁ¤100mg - »õâ
ȯÀÎÁ¦¾à
A09700941 Phenytoin
Àü¹®ÀǾàǰ | ±Þ¿©
µ¶½ÃÄÚ¸°Á¤ - »õâ
ȯÀÎÁ¦¾à
A09702671 Doxycycline hyclate
Àü¹®ÀǾàǰ | »èÁ¦
¿¡¸£´úÁøÁ¤1.5mg - »õâ
ȯÀÎÁ¦¾à
A09701151 Ergoloid Mesylate
Àü¹®ÀǾàǰ | ±Þ¿©
¿¡¸£´úÁøÁ¤1mg - »õâ
ȯÀÎÁ¦¾à
A09701381 Ergoloid Mesylate
Àü¹®ÀǾàǰ | ±Þ¿©
¶óÁ¦ÆÊÁ¤ - »õâ
ȯÀÎÁ¦¾à
G01000221 Flunitrazepam
Àü¹®ÀǾàǰ | ±Þ¿©
Æø¼¼Æ¾Ä¸½¶20mg - »õâ
ȯÀÎÁ¦¾à
A09703591 Fluoxetine HCl
Àü¹®ÀǾàǰ | ±Þ¿©
Ǫ·Îźİ¼¿ - »õâ
ȯÀÎÁ¦¾à
A09703381 Fursultiamine HCl, Hydroxocobalamin acetate, Pyridoxal phosphate, Riboflavin
ÀϹÝÀǾàǰ | ¹Ì»ý»ê
Æä¸®µ¹Á¤1.5mg - »õâ
ȯÀÎÁ¦¾à
A09701311 Haloperidol
Àü¹®ÀǾàǰ | ±Þ¿©
Æä¸®µ¹Á¤10mg - »õâ
ȯÀÎÁ¦¾à
A09701521 Haloperidol
Àü¹®ÀǾàǰ | ±Þ¿©
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • ventilate
    ȯ±â¸¦ ÇÏ´Ù
  • ventilator
    ȯ±âÀåÄ¡
  • ventilate
    ȯ±âÇÏ´Ù;(Ç÷¾×À») ½Å¼±ÇÑ °ø±â·Î Á¤È­ÇÏ´Ù;ȯ±â ÀåÄ¡¸¦ ´Þ´Ù;(¹®Á¦¸¦)°øÇ¥ÇÏ´Ù;ÀÚÀ¯·Ó°Ô Åä·ÐÇÏ´Ù
  • annulus
    ȯ´ë
  • hospitality
    ȯ´ë
  • Collins
    ȯ´ë¿¡ ´ëÇÑ ÀλçÀå;ÁøÀ» ź À½·á(ĬÅ×ÀÏÀÇ ÀÏÁ¾)
  • hospitable
    ȯ´ëÇÏ´Â
  • regale
    ȯ´ëÇÏ´Ù; ¼ºÂùÀ» ¸Ô´Ù
  • magic lantern
    ȯµî
  • magic lantern
    ȯµî±â(¿À´Ã³¯ÀÇ projector)
  • phantasmagoria
    ȯµîÀÇ ÀÏÁ¾;ÁÖ¸¶µî °°Àº ±¤°æ
  • conviviality
    ȯ¶ô
  • merrymaking
    ȯ¶ô;¼úÀÜ
  • mirth
    ȯ¶ô;À¯Äè;¸í¶û
  • Cockaigne
    ȯ¶ô°æ;·±´ø
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
  • pastime
    ¿À¶ô, ±âºÐÀüȯ, ¼ÒÀϰŸ®
  • patient
    Àγ»½ÉÀÌ °­ÇÑ,ȯÀÚ
  • phantasm
    ȯ»ó
  • phantasmic
    ȯ¿µÀÇ
  • pilular
    ȯ¾àÀÇ
  • pilulous
    ȯ¾àÀÇ
  • rapture
    ȯÈñ
  • recession
    ¹Ýȯ
  • reciprocate
    ±³È¯ÇÏ´Ù; º¸´äÇÏ´Ù
  • reciprocation
    ±³È¯
  • recreation
    ±âºÐ Àüȯ
  • recurrence
    ¹Ýº¹, ¼øÈ¯
  • recycle
    Àç¼øÈ¯ÇÏ´Ù; Àç°¡°øÇÏ´Ù
  • refection
    ±âºÐÀüȯ; ÈÞ¾ç
  • regale
    ȯ´ëÇÏ´Ù; ¼ºÂùÀ» ¸Ô´Ù
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 5
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 5
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÅëÇÕ°Ë»ö ¿Ï·á